Start an analysis for BIO
Bio-Rad Laboratories, Inc.
Stock · NYSEProgram summary
| Field | Value | As of | Source |
|---|---|---|---|
| Current authorization | $206m | 30-Sep-26 | 10-Q filed 04-Nov-26 |
| Remaining authorization | $206m | 30-Sep-26 | 10-Q filed 04-Nov-26 |
| Program expiry | n/a | — | |
| Repurchased last quarter | $0 | 30-Sep-26 | 10-Q filed 04-Nov-26 |
| Has used an ASR | No | — |
Programs
| Authorized on | Authorized | Remaining | Expires | Terms |
|---|---|---|---|---|
| Not found in filings | $206m | $206m | n/a | As of September 30, 2026, $206.0 million of stock remained available for repurchases under the Company's 2023 Share Repurchase Program, which was authorized by the Board of Directors in July 2023 and July 2024.10-Q filed 04-Nov-26 |
Open-market repurchases
- Apr ’26
- May ’26
- Jun ’26
- Jul ’26
- Aug ’26
- Sep ’26
| Month ended | Shares | Avg price | ≈ Value | Source |
|---|---|---|---|---|
| 30-Sep-26 | 0 | — | $0 | 10-Q filed 04-Nov-26 |
| 31-Aug-26 | 0 | — | $0 | 10-Q filed 04-Nov-26 |
| 31-Jul-26 | 0 | — | $0 | 10-Q filed 04-Nov-26 |
| 30-Jun-26 | 0 | — | $0 | 10-Q filed 04-Aug-26 |